Breaking News

MilliporeSigma to Provide Full Viral Vector Offering with Launch of VirusExpress 293

Adeno-Associated Virus Production Platform reduces process development time by an estimated 40 percent.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has launched the VirusExpress 293 Adeno-Associated Virus Production Platform, making it one of the first CDMOs and to provide a full viral vector manufacturing offering including AAV, Lentiviral, CDMO, CTO, and process development. This new platform aims to enable biopharmaceutical companies to increase the speed to clinical manufacturing while reducing process development time and costs.   “Cell and gene therapies offer the potential for curative treatments and can be com...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters